TL;DR
This retrospective study investigated the link between elevated aldosterone levels and blood pressure in Chinese patients with essential hypertension (EH). The findings reveal that higher aldosterone is common in EH patients and is a significant, independent risk factor for increased diastolic blood pressure, suggesting a crucial role for this hormone in hypertension management.
What Problem Does This Paper Address?
Essential hypertension (EH), the most common form of high blood pressure, affects a significant portion of the global population. While the renin-angiotensin-aldosterone system (RAAS) is well-known to regulate blood pressure, the specific role of elevated aldosterone levels in EH, particularly in non-primary aldosteronism cases, remains an area of interest. Some studies suggest that even when the aldosterone-to-renin ratio (ARR) is within normal limits, elevated aldosterone can still contribute to hypertension and its complications. This paper aims to clarify the clinical characteristics and risk factors associated with elevated aldosterone in Chinese EH patients, specifically exploring its relationship with blood pressure levels.
Methods
This was a retrospective cohort study analyzing clinical data from 309 patients diagnosed with essential hypertension. Participants were categorized into three groups based on their blood pressure (BP) levels: High (BP ≥ 160/100 mmHg), Medium (BP 140-160/90-100 mmHg), and Low (BP < 140/90 mmHg). The study measured plasma renin activity (PRA) and plasma aldosterone concentration (PAC), and calculated the aldosterone-to-renin ratio (ARR). Statistical analyses included the Wilcoxon rank sum test and chi-squared test for categorical data, and one-factor ANOVA followed by multiple linear regression analysis for multivariate analysis. The researchers specifically examined the relationship between BP levels and the activity of the RAAS components.
Datasets
The study utilized data from 309 patients with essential hypertension who were referred to the West China Hospital between January 2012 and December 2017. The data collected included demographic information, medical history, blood and urine test results, and various clinical measurements. No new datasets or benchmarks were introduced.
Key Insights and Ideas
- Aldosterone's Commonality in EH: The study highlights that elevated aldosterone levels are not rare in Chinese patients with essential hypertension, affecting over 21% of the cohort. This suggests that "inappropriate" hyperaldosteronism might be a more frequent contributor to EH than previously assumed in this population.
- Diastolic BP as the Key Indicator: A crucial finding is the strong correlation between elevated aldosterone and increased diastolic blood pressure (DBP). While systolic blood pressure showed no significant difference, DBP was consistently higher in patients with elevated aldosterone.
- Independent Risk Factor: Multiple linear regression analysis confirmed that elevated aldosterone is an independent risk factor for increased DBP in EH patients. This means that even after accounting for other variables, aldosterone itself plays a significant role in driving up diastolic pressure.
- Mechanism Hypothesis: The authors hypothesize that hyperaldosteronism might lead to extracellular fluid volume expansion, which in turn contributes to the rise in DBP. This aligns with the known effects of aldosterone on sodium and water reabsorption.
Key Results
- Out of 309 EH patients, 65 (21.04%) had elevated aldosterone levels, and 94 (30.42%) had increased renin activity.
- Patients with elevated aldosterone had significantly higher diastolic blood pressure (100 mmHg) compared to those with normal or decreased aldosterone levels (95 mmHg and 87 mmHg, respectively; p < 0.05).
- The proportion of patients with elevated aldosterone was significantly higher in the high BP group (Group H) compared to the medium and low BP groups (23.8% vs. 20.8% and 14.0%, respectively; p < 0.05).
- Multiple linear regression showed that for every 10 mmHg increase in DBP, PAC increased by 3.66 ng/dL.
- Diastolic blood pressure was found to be an independent and significant factor for predicting PAC, PRA, and ARR. Specifically, a 10% increase in DBP was associated with approximately a 5.64% increase in PAC and a 10.11% increase in PRA. Conversely, a 10% increase in DBP was associated with an approximate 8.97% decrease in ARR.
Limitations and Future Work
The authors acknowledge several limitations:
- Retrospective Design: The study's retrospective nature means it cannot establish causality definitively.
- Missing Data: Important data points like urine sodium excretion, urine aldosterone excretion, and local population daily sodium intake were not collected.
- Statistical Method Limitations: The description of the screening process and biochemical operational procedures lacked sufficient detail, and the statistical analysis methods employed had certain limitations.
Future work should include:
- Prospective Studies: Randomized controlled trials are needed to confirm these findings and establish causality.
- Comprehensive Data Collection: Future studies should incorporate the missing data points mentioned above to provide a more complete picture.
- Detailed Methodological Descriptions: Enhanced detail in describing screening processes and biochemical procedures will improve reproducibility and understanding.
Summary updated